Nika Pharmaceuticals (NIKA) Shares Outstanding (Diluted) (2021 - 2026)
Nika Pharmaceuticals' Weighted Average Shares Outstanding (Diluted) came in at 876.09 million for Q4 2023, up 21.0% from 723.95 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Nika Pharmaceuticals (NIKA) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Going back to Q1 2021, Nika Pharmaceuticals' Weighted Average Shares Outstanding (Diluted) data covers 12 quarters.
- Going back by year, Weighted Average Shares Outstanding (Diluted) was 723.95 million in FY2022 (+82.8%) and 396.09 million in FY2021.
- Year-over-year, Weighted Average Shares Outstanding (Diluted) has increased for three consecutive quarters, with growth averaging 44.9% over the last seven quarters.
- Business Quant data shows NIKA's Weighted Average Shares Outstanding (Diluted) at 876.09 million (Q3 2023), 876.09 million (Q2 2023) and 876.09 million (Q1 2023) in the three quarters before Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Nika Pharmaceuticals | 369.14 Mn | 369.13 Mn | - | 1.05 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.05 Bn |
| Jun 30, 2026 | 1.05 Bn |
| Mar 31, 2026 | 1.05 Bn |
| Dec 31, 2025 | 1.05 Bn |
| Sep 30, 2025 | 1.04 Bn |
| Jun 30, 2025 | 1.03 Bn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | 1.02 Bn |
| Sep 30, 2024 | 1.02 Bn |
| Jun 30, 2024 | 1.02 Bn |
| Mar 31, 2024 | 876.09 Mn |
| Dec 31, 2023 | 876.09 Mn |
| Sep 30, 2023 | 876.09 Mn |
| Jun 30, 2023 | 876.09 Mn |
| Mar 31, 2023 | 876.09 Mn |
| Dec 31, 2022 | 723.95 Mn |
| Sep 30, 2022 | 740.60 Mn |
| Jun 30, 2022 | 740.60 Mn |
| Mar 31, 2022 | 13.20 Mn |
| Dec 31, 2021 | 396.09 Mn |
API Access
Nika Pharmaceuticals Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NIKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "NIKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NIKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();